Study A

• Phase II/III Trial Imaging Trial
• NSTEMI
• Objective: diagnostic performance metrics.
• Drug Class: metabolic imaging agents

Study B

• Phase I Myocardial Regenerative Therapy Trial
• STEMI
• Objective:  safety and efficacy
• Drug Class: regenerative therapies

Study C

• Observational Study of diagnositc device in ED
• ACS
• Objective: determining performance characteristics of of device
• Drug/Device Class:  ED diagnosis of ACS

Study D

• Phase IV
• Coronary Artery Disease
• Objective: measure long term cardiovascular events
• Drug Class: Pharmaceutical Agent used in nuclear medicine